InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
TLR4-based adjuvant - MPLA-SM VacciGrade™ | Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-lik... | 2022 | Viruses | Gomes K.B. et al. | DOI: 10.3390/v14091920 |
Alhydrogel® adjuvant 2% | Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-lik... | 2022 | Viruses | Gomes K.B. et al. | DOI: 10.3390/v14091920 |
QUANTI-Blue™ | Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an An... | 2022 | Biomedicines | Schepetkin I.A. et al. | DOI: 10.3390/biomedicines10092119 |
THP1-Blue™ NF-κB Cells | Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an An... | 2022 | Biomedicines | Schepetkin I.A. et al. | DOI: 10.3390/biomedicines10092119 |
2’3’-cGAM(PS)2 (Rp/Sp) | Immune checkpoint inhibition improves antimyeloma activity of bortezomib and ... | 2022 | Clin Exp Med. | Sokolowska O. et al. | DOI: 10.1007/s10238-022-00878-1 |
LumiKine™ Xpress mIFN-β 2.0 | Immune checkpoint inhibition improves antimyeloma activity of bortezomib and ... | 2022 | Clin Exp Med. | Sokolowska O. et al. | DOI: 10.1007/s10238-022-00878-1 |
Alhydrogel® adjuvant 2% | Alum-anchored intratumoral retention improves the tolerability and antitumor ... | 2022 | PNAS | Lutz E.A. et al. | DOI: 10.1073/pnas.2205983119 |
Primocin® | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
HEK-Blue™ Selection | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
HKSA | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
IL-10 Reporter HEK 293 Cells | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
QUANTI-Blue™ | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
HKEB | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
IL-6 Reporter HEK 293 Cells | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
Normocin® - Antimicrobial Reagent | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
HKMT | Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals wide... | 2022 | Nat Commun. | Oelen R. et al. | DOI: 10.1038/s41467-022-30893-5 |
PMA - Phorbol myristate acetate | Immunogenicity and protectivity of intranasally delivered vector-based hetero... | 2022 | Emerg Microbes Infect. | Tukhvatulin A.I. et al. | DOI: 10.1080/22221751.2022.2119169 |
PlasmoTest™ - Mycoplasma Detection Kit | A novel serum extracellular vesicle protein signature to monitor glioblastoma... | 2022 | Int J Cancer | Tzaridis T. et al. | DOI: 10.1002/ijc.34261 |